查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590819

基因组工程市场：按技术、应用和最终用户划分 - 2025-2030 年全球预测

Genome Engineering Market by Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因组工程市值为63.3亿美元，预计2024年将达到73.2亿美元，复合年增长率为15.68%，到2030年将达到175.7亿美元。

基因组工程是生物技术中的一个变革领域，涵盖了为操纵生物体遗传物质而开发的技术和方法。其范围包括 CRISPR-Cas9、TALEN 和 ZFN 等技术，为基因治疗、农业和合成生物学等领域开闢了可能性。基因组工程的需求在于其解决遗传疾病、作物復原力和生质燃料开发等广泛挑战的潜力。其应用范围广泛，包括治疗应用，例如根除遗传疾病、透过基因改造作物提高农业生产力以及透过基于基因组资料客製化治疗来推进个人化医疗。

主要市场统计
基准年[2023] 63.3亿美元
预测年份 [2024] 73.2亿美元
预测年份 [2030] 175.7亿美元
复合年增长率（%） 15.68%

最终用途包括医疗保健、农业、製药和工业生物技术。该市场的关键成长要素包括基因组编辑技术的进步、政府和私人机构资金的增加以及对改善健康结果和粮食安全的生物技术创新的需求不断增加。新的商机不断出现，特别是在基因治疗和精准医学领域，这些市场有望从实现精确基因改造的突破性技术中获益匪浅。鼓励公司投资研发，专注于开发改进、高效且具成本效益的基因组编辑工具，同时了解法律规范和道德考量。

然而，该市场面临限制和挑战，包括有关基因操纵的伦理问题以及阻碍快速商业化的严格监管要求。基因组编辑程式的高成本和某些地区有限的技术专业知识也构成了主要障碍。创新和研究应该旨在克服这些困难。有前途的领域包括推进交付机制以提高效率和降低成本，探索微生物组工程的新应用，以及开发用于害虫控制的环境友善基因驱动器。

总体而言，以快速成长和技术进步为特点的基因组工程市场提供了巨大的机会，但要充分发挥其潜力，您必须对道德和监管环境进行策略性调整。

市场动态：揭示快速发展的基因组工程市场的关键市场洞察

供需的动态交互作用正在改变基因组工程市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 生物技术中对合成基因的需求不断增长
    • 更多采用 CRISPR 基因组编辑技术
    • 全球诊断技术的采用率不断提高
  • 市场限制因素
    • 基因组工程的设备/系统成本高
  • 市场机会
    • 基因编辑工具的持续技术发展
    • 个人化医疗的新应用
  • 市场挑战
    • 与基因工程相关的问题

波特五力：驾驭基因组工程市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因组工程市场的外部影响

外部宏观环境因素在塑造基因组工程市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解基因组工程市场的竞争状况

基因组工程市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因组工程市场供应商绩效评估

FPNV定位矩阵是评估基因组工程市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了基因组工程市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基因组工程市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物技术领域对合成基因的需求增加
      • 扩大CRISPR基因组编辑技术的引进
      • 全球诊断技术的采用率不断增加
    • 抑制因素
      • 基因组工程设备/系统成本高
    • 机会
      • 基因编辑工具的持续技术发展
      • 个人化医疗的新应用
    • 任务
      • 与基因工程相关的问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因组工程市场：依技术分类

  • 短的、有规则间隔的回文重复
  • 转录激活剂样效应核酸酶
  • 锌指核酸酶

第七章 基因组工程市场：依应用分类

  • 动物基因工程
  • 细胞株工程
  • 植物基因组工程

第 8 章 基因组工程市场：依最终使用者分类

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约研究组织

第九章 北美和南美基因组工程市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太基因组工程市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的基因组工程市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bluebird Bio, Inc.
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group PLC
  • Intellia Therapeutics, Inc.
  • Lonza Group AG
  • Merck & Co., Inc.
  • New England Biolabs
  • Origene Technologies
  • Precision BioSciences, Inc.
  • Sangamo Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Transposagen Biopharmaceuticals, Inc.
Product Code: MRR-437E9896A515

The Genome Engineering Market was valued at USD 6.33 billion in 2023, expected to reach USD 7.32 billion in 2024, and is projected to grow at a CAGR of 15.68%, to USD 17.57 billion by 2030.

Genome engineering, a transformative area within biotechnology, encompasses techniques and technologies developed to manipulate an organism's genetic material. Its scope includes methods such as CRISPR-Cas9, TALENs, and ZFNs, which have broadened possibilities in areas like gene therapy, agriculture, and synthetic biology. The necessity of genome engineering lies in its potential to address pervasive challenges such as genetic disorders, crop resilience, and the development of biofuels. Its applications are diverse, covering therapeutic uses like eradicating genetic diseases, enhancing agricultural productivity through genetically modified crops, and advancing personalized medicine by customizing treatments based on genomic data.

KEY MARKET STATISTICS
Base Year [2023] USD 6.33 billion
Estimated Year [2024] USD 7.32 billion
Forecast Year [2030] USD 17.57 billion
CAGR (%) 15.68%

The end-use scope spans healthcare, agriculture, pharmaceuticals, and industrial biotechnology. Key growth influencers in this market include advancements in genome editing technologies, increasing funding from government bodies and private institutions, and rising demand for biotechnological innovations to improve health outcomes and food security. Emerging opportunities are particularly visible in gene therapy and precision medicine, with markets poised to benefit significantly from breakthroughs that allow for precise genetic modifications. Companies are advised to invest in R&D, focusing on the development of improved, efficient, and cost-effective genome editing tools while keeping abreast of regulatory frameworks and ethical considerations.

However, the market faces limitations and challenges, including ethical concerns around genetic manipulation and stringent regulatory requirements that can hinder rapid commercialization. High costs associated with genome editing procedures and limited technical expertise in some regions also pose significant hurdles. Innovation and research should target overcoming these difficulties, with promising areas including advancements in delivery mechanisms to improve efficiency and reduce costs, exploring novel applications in microbiome engineering, and developing eco-friendly gene drives for pest control.

Overall, the genome engineering market, characterized by rapid growth and technological advancements, presents significant opportunities but requires strategic navigation of ethical and regulatory landscapes to realize its full potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Engineering Market

The Genome Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for synthetic gene in biotechnology sector
    • Rising implementation of CRISPR genome editing technology
    • Increasing adoption in diagnostics sector worldwide
  • Market Restraints
    • High equipment/systems costs in genome engineering
  • Market Opportunities
    • Constant technological developments in gene-editing tools
    • Emerging application in personalized medicine
  • Market Challenges
    • Issues associaetd with genetic engineering

Porter's Five Forces: A Strategic Tool for Navigating the Genome Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genome Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genome Engineering Market

A detailed market share analysis in the Genome Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Engineering Market

A strategic analysis of the Genome Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Engineering Market, highlighting leading vendors and their innovative profiles. These include Bluebird Bio, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Intellia Therapeutics, Inc., Lonza Group AG, Merck & Co., Inc., New England Biolabs, Origene Technologies, Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Transposagen Biopharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Genome Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease.
  • Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for synthetic gene in biotechnology sector
      • 5.1.1.2. Rising implementation of CRISPR genome editing technology
      • 5.1.1.3. Increasing adoption in diagnostics sector worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High equipment/systems costs in genome engineering
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant technological developments in gene-editing tools
      • 5.1.3.2. Emerging application in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associaetd with genetic engineering
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genome Engineering Market, by Technology

  • 6.1. Introduction
  • 6.2. Clustered Regularly Interspaced Short Palindromic Repeats
  • 6.3. Transcription Activator-like Effector Nuclease
  • 6.4. Zinc Finger Nuclease

7. Genome Engineering Market, by Application

  • 7.1. Introduction
  • 7.2. Animal Genetic Engineering
  • 7.3. Cell Line Engineering
  • 7.4. Plant Genome Engineering

8. Genome Engineering Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Genome Engineering Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Genome Engineering Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Genome Engineering Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bluebird Bio, Inc.
  • 2. CRISPR Therapeutics AG
  • 3. Danaher Corporation
  • 4. Editas Medicine, Inc.
  • 5. GenScript Biotech Corporation
  • 6. Horizon Discovery Group PLC
  • 7. Intellia Therapeutics, Inc.
  • 8. Lonza Group AG
  • 9. Merck & Co., Inc.
  • 10. New England Biolabs
  • 11. Origene Technologies
  • 12. Precision BioSciences, Inc.
  • 13. Sangamo Therapeutics, Inc.
  • 14. Thermo Fisher Scientific Inc.
  • 15. Transposagen Biopharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. GENOME ENGINEERING MARKET RESEARCH PROCESS
  • FIGURE 2. GENOME ENGINEERING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOME ENGINEERING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOME ENGINEERING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ZINC FINGER NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOME ENGINEERING MARKET SIZE, BY PLANT GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOME ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023